Computed tomography appearance of the prostatic fossa following radical prostatectomy
- PMID: 9419593
- DOI: 10.1016/s1076-6332(05)80401-5
Computed tomography appearance of the prostatic fossa following radical prostatectomy
Abstract
Rationale and objectives: We assessed the value of postsurgical computed tomography (CT) in detecting locally recurrent prostatic carcinoma and determined the most effective CT findings.
Methods: We studied 13 patients with recurrent disease (prostate specific antigen [PSA] > 0.4 ng/ml) and 11 patients with no evidence of recurrence (PSA < 0.3 ng/ml). Pelvic CT scans were independently interpreted by four readers who were unaware of patient status. Readers measured tissue volume in the prostatic fossa and evaluated each scan for the presence of six potentially discriminating criteria. We determined sensitivity and specificity and developed mean and pooled receiver operating characteristic (ROC) curves for each criterion and for overall rating.
Results: The respective mean ROC curves, sensitivity, and specificity for each criterion were as follows: irregular tissue margins = .50, .67, and .32; inhomogeneous tissue density = .35, .76, and .11; asymmetric residual seminal vesicles = .68, .86, and .16; fat infiltration around seminal vesicles = .67, .69, and .43; infiltration of perirectal fat = .60, .71, and .40; and margins of the levator ani = .50, .78, and .09. The overall rating of whether a scan was normal or reflected recurrent cancer was .56, .75, and .32. Mean tissue volume in the prostatic fossa was 15.01 cm3 for the positive cases and 11.06 cm3 for the negative cases (p < .05), but because of a large overlap, this difference was not practically significant.
Conclusion: CT scanning is not an effective technique for detecting recurrent prostate malignancy. Normally, there is a moderate amount of soft tissue in the prostatic fossa postoperatively that should not be confused for malignancy.
Similar articles
-
Clinical utility of indium 111-capromab pendetide immunoscintigraphy in the detection of early, recurrent prostate carcinoma after radical prostatectomy.Cancer. 2002 Feb 15;94(4):987-96. Cancer. 2002. PMID: 11920467
-
[11C]choline PET/CT imaging in occult local relapse of prostate cancer after radical prostatectomy.Eur J Nucl Med Mol Imaging. 2008 Jan;35(1):9-17. doi: 10.1007/s00259-007-0530-2. Epub 2007 Sep 9. Eur J Nucl Med Mol Imaging. 2008. PMID: 17828534
-
Sensitivity of computed tomography in detecting local recurrence of prostatic carcinoma following radical prostatectomy.Br J Radiol. 1997 Oct;70(838):995-9. doi: 10.1259/bjr.70.838.9404201. Br J Radiol. 1997. PMID: 9404201
-
Capromab Pendetide imaging of prostate cancer.Cancer Biother Radiopharm. 2000 Apr;15(2):131-40. doi: 10.1089/cbr.2000.15.131. Cancer Biother Radiopharm. 2000. PMID: 10803318 Review.
-
Beyond the nerve-sparing radical prostatectomy.Cancer Treat Res. 1996;88:129-45. doi: 10.1007/978-1-4615-6343-3_8. Cancer Treat Res. 1996. PMID: 9239477 Review. No abstract available.
Cited by
-
Value of fused 18F-Choline-PET/MRI to evaluate prostate cancer relapse in patients showing biochemical recurrence after EBRT: preliminary results.Biomed Res Int. 2014;2014:103718. doi: 10.1155/2014/103718. Epub 2014 Apr 30. Biomed Res Int. 2014. PMID: 24877053 Free PMC article. Clinical Trial.
-
PET/CT imaging of recurrent prostate cancer.Eur J Nucl Med Mol Imaging. 2008 Jan;35(1):5-8. doi: 10.1007/s00259-007-0633-9. Eur J Nucl Med Mol Imaging. 2008. PMID: 17985129 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials
Miscellaneous